Drug profile · INN
lisdexamfetamine
VYVANSE
lisdexamfetamine (VYVANSE) is a dopamine transporter releasing agent. Associated with Lacuna Pharma Pty Ltd.
TGA: approved
Patents linked 0
Pipeline programs 26
News articles 0
Drug details — lisdexamfetamine
- Class
- —
- Route
- —
- Patents
- 0
- Programs
- 26
- Data quality
- 0.81
Quick answer
lisdexamfetamine (VYVANSE) is a dopamine transporter releasing agent. Associated with Lacuna Pharma Pty Ltd.
Key facts
INN lisdexamfetamine
Brand VYVANSE
Mechanism Dopamine transporter releasing agent
Originator Lacuna Pharma Pty Ltd
Mechanism of action
Dopamine transporter releasing agent
Approval history
| Authority | Status | Date |
|---|---|---|
| TGA | approved | — |
Pipeline programs
- Antidepressant + SPD489 (Lisdexamfetamine dimesylate) 10 mg
- Lisdexamfetamine Dimesylate (LDX)
- Lisdexamfetamine dimesylate
- SPD489 (Lisdexamfetamine dimesylate)
- SPD489 (Lisdexamfetamine dimesylate)
- SPD489 (Lisdexamfetamine dimesylate) + Antidepressant
- Vyvanse (lisdexamfetamine dimesylate)
- Lisdexamfetamine
Frequently asked questions
What is lisdexamfetamine?
lisdexamfetamine (VYVANSE) is a dopamine transporter releasing agent. Associated with Lacuna Pharma Pty Ltd.
What is the brand name for lisdexamfetamine?
VYVANSE is a marketed brand name for lisdexamfetamine. Check FDA Drugs@FDA for the current US label holder and prescribing information.